DBI and hepatocellular carcinoma: This preclinical evidence in favor of pro-HCC effects of ACBP/DBI is backed up by clinical correlations showing that aggressive HCC is associated with the upregulation of DBI mRNA, as well as with an increase in circulating ACBP/DBI protein concentrations.